FABBS reports on items of interest to many communities – scientists, policymakers, and the public. In our news, you will see updates on science funding and policy, articles that translate research for policy, and descriptions of the research contributions of scientists at all stages of their research careers.
FABBS Honors Warren H Meck
February 13, 2020
WARREN H. MECKSCHOLAR, MENTOR, FRIEND17 November 1956 – 21 January 2020
Throughout his long career, Professor Warren H. Meck systematically uncovered and explained the mechanisms that allow humans (and other animals) to mark the passage of time in the seconds to minutes range – a process now known as “interval timing”. He crossed traditional disciplinary boundaries and had profound impact upon psychology, cognitive science, behavioral neuroscience, and even
read moreRecent Honors and Awards in Our Sciences
February 13, 2020
In late January, The National Academy of Sciences announced
the recipients of their annual awards
honoring outstanding achievement in the physical, biological, and social
sciences. Amongst these awardees were several behavioral and cognitive
scientists from our member societies and affiliates. These awards will be
presented on April 26 during the Academy’s 157th annual meeting.
The Atkinson Prize in Psychological and Cognitive Sciences
is presented to honor significant
President’s Budget Released, Eyes Turn to Congress
February 12, 2020
On February 10th, the administration kicked off the annual federal budgeting process by releasing a proposed budget for fiscal year (FY) 2021. For the fourth straight year, President Donald Trump proposed sizable reductions in federal research budgets of the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Institute of Education Sciences (IES). Congress has not only rejected similar proposed cuts in the past, but also provided
read moreClinical Trial Definition Continues to Cause Confusion
February 12, 2020
Towards the end of January, FABBS started receiving emails from worried researchers saying their proposals to NIH had been withdrawn before review because they were not classified as clinical trials, and perception was that they should have been. As readers may recall, in October 2014, NIH expanded their definition of clinical trials to include Basic Experimental Studies involving Humans (BESH). While the enforcement of registration in grants.gov for BESH had been
read more